People's IPO inquiry has been submitted to the Shanghai Stock Exchange, making it the largest comprehensive bearing manufacturing group in the country.
On January 22nd, Renben Co., Ltd. (hereinafter referred to as Renben Co.) applied for a status change in the Shanghai Stock Exchange main board listing review to "inquiry received". Citic Securities will be its sponsor institution and it plans to raise 3.8 billion yuan.
On January 22, Renben Co., Ltd. (hereinafter referred to as Renben Co.) applied for a status change in the listing review on the Shanghai Stock Exchange Main Board to "Has been queried" with CITIC SEC as its sponsor, planning to raise 3.8 billion yuan.
According to the prospectus, the company mainly engages in the research and development, production, and sales of bearings and related products, and is the largest comprehensive bearing manufacturing group in China with the most complete range of products. The company's business covers more than 70 countries and regions worldwide, with nine production bases established at home and abroad, nearly 20,000 employees, and the capability to research and manufacture the entire industry chain from bearing materials, components to finished bearings. The company's bearing products have over 50,000 types and specifications, widely used in industries such as the automotive industry, light machinery, heavy machinery, and major equipment in many important sectors of the national economy. Since 2013, the company has ranked first in domestic production and sales for twelve consecutive years. With comprehensive technology, product quality, and business scale rapidly approaching the top eight international companies in the bearing industry, the company is currently the only Chinese enterprise to enter the top ten in the global bearing industry.
The company continues to serve outstanding enterprises in various industrial fields. In the automotive industry, the company's end customers cover domestic and foreign well-known automotive brands such as FAW, Dongfeng, Changan, Great Wall, Geely, Chery, BYD Company Limited, NIO, XPENG, IDEAL, Volkswagen, Toyota, Audi, Mercedes-Benz, and BMW; in the field of light machinery, the company's end customers include domestic and overseas well-known home appliance motor companies such as Midea, Haier, Dyson, Panasonic, Whirlpool, and Nidec, as well as several well-known Siasun Robot & Automation companies in China; in the field of heavy machinery, the company's end customers include domestic and foreign well-known engineering machinery enterprises such as XCMG Construction Machinery, Sany Heavy Industry, ZOOMLION, Caterpillar, John Deere, and Mitsubishi Heavy Industries; in the field of major equipment, the company has established cooperative relationships with well-known equipment manufacturers such as CRRC Corporation and China Railway Equipment. In addition, the company stably supplies bearing components to several international top eight bearing companies.
Currently, the company has become the largest comprehensive bearing manufacturing group in China in terms of scale and product range, with significantly higher revenue scale and market share than other domestic bearing companies, continuously ranking first in domestic production and sales since 2013, and has become the only Chinese enterprise to enter the top ten in the global bearing industry. In recent years, the company has focused on the key core technologies of bearings for major equipment such as rail transportation, wind power generation, shield machines, and precision machine tools, making significant breakthroughs in multiple technology products, achieving batch supply, and significantly enhancing the competitiveness of high-end bearing market.
Financially, in 2022, 2023, 2024, and January-June 2025, the company achieved operating income of approximately 9.388 billion yuan, 10.482 billion yuan, 11.960 billion yuan, and 6.471 billion yuan respectively; During the same period, the net profit was approximately 635 million yuan, 701 million yuan, 829 million yuan, and 442 million yuan respectively.
Related Articles

New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


